After years of limited success, researchers have found a way to convert type A blood cells into the more universal type O by leveraging human gut bacteria, according to a report in the magazine Science.

Canadian researchers have singled out a peptide known as apelin that could improve survival in CV patients with aortic aneurysms, leading them to dub the molecule the equivalent of insulin for heart disease.

Teva Pharmaceuticals is pulling six bulk lots of its angiotensin II receptor blocker losartan from the market after testing revealed dangerously high levels of N-Nitroso-N-methyl-4-aminobutyric acid, a probable human carcinogen, in the drugs.

A collaboration between cardiologists and dentists at the Karolinska Institutet in Sweden has linked undetected glucose disorders like diabetes to an increased risk of myocardial infarction and periodontitis, a severe gum disease.

Heart patients with untreated white coat hypertension are more than twice as likely to die from cardiovascular disease as their normotensive counterparts, according to a June 11 study.

More than 14 million European adults aged 65 and up will have developed atrial fibrillation by 2060, according to a paper published June 6 in EP Europace.

Mount Sinai Heart announced June 10 that a pair of its top cardiothoracic surgeons succeeded in performing two totally endoscopic coronary arterial bypass surgeries (TECABs) at the end of May, making the hospital the only center in New York State qualified to offer the procedure.

Ultrathin drug-eluting stents performed better than their thicker counterparts in a recent analysis of the BIO-RESORT trial, researchers reported in JAMA Cardiology May 21—but thinner struts might not always be the right go-to for patients after PCI.